GLP-1 Medicines While Breastfeeding: What FDA Labels Say

Educational, not medical advice

This content is for general information only. It is not medical advice, a diagnosis, or a treatment plan. Beema Health's live clinical offering is telehealth medical weight-loss. Beema Health serves patients located in the United States only. It is not an international service. Licensed providers can evaluate adults in all 50 US states through telehealth. A licensed clinician reviews each intake and decides whether any medication is appropriate. Completing an online intake does not guarantee a prescription. Compounded semaglutide is not FDA-approved and is considered only when legally available and clinically appropriate. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate. They are not the same as FDA-approved branded products. This library does not promise weight-loss results, show before-and-after photos, or collect health information.

This is a label summary, not a feeding plan

Infant feeding is a medical and family decision. Prescription incretin medicines have short, incomplete lactation sections. This article restates those sections in plain language so you can have a better visit. It does not tell you to wean, to continue, or to start a GLP-1. Beema Health does not collect pumping logs or infant health information on this marketing site.

If you are pregnant, several products say to discontinue when pregnancy is recognized for weight-reduction use, because weight loss is not recommended in pregnancy and animal data raise fetal-harm concerns. That is a separate emergency from lactation. Get obstetric advice promptly.

Tablets versus injections: the Wegovy split

Wegovy tablets contain SNAC to help absorb semaglutide. The label states that breastfeeding is not recommended during treatment with Wegovy tablets. Injection Wegovy does not contain those SNAC metabolites. For the injection, the PI says there are no data on presence of subcutaneously administered semaglutide in human milk, on the breastfed infant, or on milk production, and then uses the standard benefit-risk sentence.

That split is easy to miss in social media posts that say “Wegovy and breastfeeding” as if there were one product. Confirm whether you have a pen or a bottle.

What little tirzepatide milk data exist

Zepbound’s PI describes a single-dose lactation study: after 5 mg in healthy lactating adults, tirzepatide in milk was undetectable or low compared with the maternal dose. There are still no data on infant effects or milk production. Clinicians are told to consider the developmental and health benefits of breastfeeding along with the mother’s clinical need and possible adverse effects on the infant from the drug or the underlying condition.

A low milk concentration in 11 adults after one dose is not the same as long-term safety at maintenance doses in a real postpartum population. Do not treat that study as a green light. Do not treat it as a red light without a clinician either. It is a limited observation.

How LactMed and CDC fit next to the PI

LactMed summarizes published lactation data and can lag or differ in tone from a manufacturer PI. It is a useful second source for clinicians, not a consumer override. CDC breastfeeding guidance is about feeding practices and support, not about authorizing a weekly peptide.

If two sources seem to disagree, the prescriber and the infant’s clinician should reconcile them with your exact drug, dose, infant age, and health. Premature or medically fragile infants change the risk conversation.

What to bring to the visit

Bring the exact product name, dose, and how you feed (exclusive human milk, mixed, formula). Bring the infant’s age and any health issues. Ask what is known, what is unknown, and what monitoring would look like if medicine continues or if it waits. Ask about contraception; tirzepatide can reduce oral contraceptive exposure during initiation and dose increases.

Do not stop an antidepressant or a thyroid medicine on your own because you are also discussing a GLP-1. Those have their own perinatal rules. See the related medical-consideration articles.

Frequently asked questions

Is it safe to take a GLP-1 while breastfeeding?

That word “safe” is a clinician judgment, not a website output. Wegovy tablets: the U.S. label says breastfeeding is not recommended during treatment. Wegovy injection: there are no data on presence in human milk, infant effects, or milk production; clinicians are told to weigh the benefits of breastfeeding against the mother’s need for the drug and possible infant effects. Zepbound: a small lactation study found tirzepatide undetectable or low in milk relative to the maternal dose, with no data on infant effects or milk production, and the same benefit-risk sentence. Do not start, stop, or “pump and dump” on the basis of this FAQ.

Does pumping and dumping make semaglutide safe?

Labels do not describe a pump-and-dump protocol for these weekly injections. Semaglutide has a long half-life (the Wegovy label uses a two-month gap before planned pregnancy for that reason). Dumping milk for a day does not match that pharmacology. This is not a recommendation to wean or to continue. It is a reason to involve a clinician who can discuss feeding goals and alternatives.

What about Ozempic or Mounjaro while nursing?

Those products have their own lactation subsections. They are adult diabetes brands, not automatically interchangeable with Wegovy or Zepbound. Read the PI for the exact product dispensed, or ask the pharmacist to walk through section 8.2 with you. This page does not convert diabetes care into a weight-loss plan.

Can GLP-1s reduce milk supply?

Adequate data on milk production are lacking for several products. Rapid calorie deficits, dehydration from vomiting, and some other medicines can affect supply. CDC breastfeeding guidance still treats human milk as important for infant health when it is the chosen feeding method. Report supply changes to both the infant’s clinician and the prescriber.

I want to lose baby weight while nursing. What should I do?

Postpartum weight and feeding goals belong with obstetric, pediatric, and, if used, obesity clinicians together. Weight loss is not recommended during pregnancy. After delivery, the labeled lactation language still applies. See the postpartum article. Do not use a marketing BMI quiz that collects infant or pumping details.

Are compounded GLP-1s better studied in lactation?

This article does not compare compounded products with FDA-approved brands. Compounded drugs are not FDA-approved finished products. Lack of a brand name does not create lactation data. Ask a clinician about the specific product you were offered.

Sources

Related education

Program pages

These pages describe Beema's live medical weight-loss offering. They are commercial pages, not this educational article.

Beema's live offering is medical weight-loss care

Licensed providers can evaluate adults in all 50 US states through telehealth. Beema Health serves patients located in the United States only. It is not an international service. A licensed clinician reviews each intake and decides whether any medication is appropriate. Completing an online intake does not guarantee a prescription. Compounded semaglutide is not FDA-approved and is considered only when legally available and clinically appropriate. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate.

Beema Health is a LegitScript-certified website. Certification means the certified site is monitored against LegitScript's healthcare merchant standards. It is not an endorsement of Beema's products, not a statement that compounded medication is safe or FDA-approved, and not a claim about competitors. Beema Health has obtained Google's healthcare certification for prescription-drug advertising in the United States. That certification is about advertising eligibility. It is not a Google endorsement of Beema, of any medication, or of any clinical outcome.

See if a provider-reviewed plan could be right for you

Breastfeeding and GLP-1 medicines: labeled lactation language, not a personal order